Author name: Yali Friedman

REDISCOVERING NATURAL PRODUCTS Cast aside for years, natural products drug discovery appears to be reclaiming attention and on the verge […]

Biotech funding on track to bounce back It’s not over yet, but 2003 already looks like a banner year for

Popping a pill could fix gene defect Simply popping a pill might be enough to overcome the type of genetic

Monsanto Overhauling Businesses Monsanto, the world’s leading agricultural biotechnology company, says it is abandoning efforts to produce pharmaceuticals in genetically

Cloning Remains a Meaty Issue The Food and Drug Administration soon will decide whether the meat in your Philly cheese

Sabotage of biotech firms grows A growing militant movement opposed to genetic engineering in agriculture and medicine is turning to

High hopes for biotech companies / IPOs getting ready to go as startups woo VC investors Biotechnology leaders are cautiously

Reducing Multi-Cycle Reviews Is FDA Priority FDA Commissioner Mark McClellan today described key steps the agency is taking to shorten

Reaping and Sewing From Corn The National Renewable Energy Lab and chemical company DuPont have teamed to design a versatile

Enigmatic ImClone Rarely has a company reeling from corporate malfeasance been on the receiving end of so much good news.